目次

1. EXECUTIVE SUMMARY
1.1. OVERVIEW
1.2. MARKET
1.3. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR
1.4. GLOBAL COLLAGEN AND HYALURONIC ACID
1.5. GLOBAL COLLAGEN AND HYALURONIC
1.6. GLOBAL
1.7. DEFINITION
1.8. SCOPE OF THE STUDY
1.9. RESEARCH
1.10. MARKET STRUCTURE

2. RESEARCH METHODOLOGY
2.1. OVERVIEW
2.2. DATA FLOW
2.2.1. DATA MINING PROCESS
2.3. PURCHASED DATABASE:
2.3.1. SECONDARY RESEARCH DATA FLOW:
2.4. PRIMARY RESEARCH:
2.4.1. PRIMARY RESEARCH DATA FLOW:
2.4.2. PRIMARY RESEARCH: NUMBER OF INTERVIEWS
2.4.3. PRIMARY RESEARCH: REGIONAL COVERAGE
2.5. APPROACHES FOR
2.5.1. REVENUE ANALYSIS APPROACH
2.6. DATA FORECASTING
2.6.1. DATA FORECASTING TYPE
2.7. DATA MODELING
2.7.1. MICROECONOMIC FACTOR
2.7.2. DATA MODELING:
2.8. TEAMS AND ANALYST CONTRIBUTION
2.9. INTRODUCTION
2.10. DRIVERS
2.10.1. RISING PREVALENCE
2.10.2. GROWING AGING POPULATION
2.10.3. HIGH COST OF TREATMENT
2.10.4. REGULATORY CHALLENGES
2.11. OPPORTUNITY
2.11.1. GROWING DEMAND FOR MINIMALLY INVASIVE TREATMENTS

3. MARKET FACTOR ANALYSIS
3.1. VALUE CHAIN ANALYSIS
3.1.1. R&D
3.1.2. DISTRIBUTION AND SALES
3.1.3. POST-SALES MONITORING
3.2. PORTER'S FIVE FORCES MODEL
3.2.1. THREAT OF NEW ENTRANTS
3.2.2. BARGAINING
3.2.3. THREAT OF SUBSTITUTES
3.2.4. BARGAINING POWER
3.2.5. INTENSITY OF RIVALRY

4. GLOBAL COLLAGEN AND HYALURONIC
4.1. OVERVIEW
4.2. COLLAGEN INJECTION
4.3. COMBINATION OF HYALURONIC

5. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS
5.1. OVERVIEW
5.2. KNEE OSTEOARTHRITIS
5.3. JOINT
5.4. VETERINARY APPLICATIONS
5.5. POST-OPERATIVE RECOVERY

6. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET,
6.1. OVERVIEW
6.2. HOSPITAL PHARMACIES
6.3. ONLINE PHARMACIES

7. GLOBAL COLLAGEN AND HYALURONIC
7.1. OVERVIEW
7.2. NORTH
7.2.1. US
7.2.2. CANADA
7.3. EUROPE
7.3.1. GERMANY
7.3.2. FRANCE
7.3.3. RUSSIA
7.3.4. SPAIN
7.3.5. ITALY
7.4. ASIA PACIFIC
7.4.1. CHINA
7.4.2. INDIA
7.4.3. SOUTH KOREA
7.4.4. MALAYSIA
7.4.5. THAILAND
7.4.6. REST OF ASIA PACIFIC
7.5. LATIN AMERICA
7.5.1. BRAZIL
7.5.2. MEXICO
7.5.3. ARGENTINA
7.5.4. REST OF LATIN AMERICA
7.6. MIDDLE
7.6.1. GCC COUNTRIES
7.6.2. SOUTH AFRICA
7.6.3. REST

8. COMPETITIVE LANDSCAPE
8.1. INTRODUCTION
8.2. MARKET SHARE
8.3. COMPETITOR DASHBOARD
8.4. PUBLIC PLAYERS STOCK SUMMARY
8.5. COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
8.6. KEY DEVELOPMENTS &
8.6.1. PRODUCT LAUNCH/APPROVAL

9. COMPANY PROFILES
9.1. SEIKAGAKU CORPORATION
9.1.1. COMPANY OVERVIEW
9.1.2. FINANCIAL
9.1.3. PRODUCTS OFFERED
9.1.4. KEY DEVELOPMENTS
9.1.5. SWOT
9.1.6. KEY STRATEGIES
9.2. BIOVENTUS, INC.
9.2.1. COMPANY
9.2.2. FINANCIAL OVERVIEW
9.2.3. PRODUCTS OFFERED
9.2.4. SWOT ANALYSIS
9.2.5. KEY STRATEGIES
9.2.6. COMPANY OVERVIEW
9.2.7. FINANCIAL OVERVIEW
9.2.8. PRODUCTS OFFERED
9.2.9. KEY DEVELOPMENTS
9.2.10. SWOT ANALYSIS
9.2.11. KEY STRATEGIES
9.3. ZIMMER BIOMET
9.3.1. COMPANY OVERVIEW
9.3.2. FINANCIAL OVERVIEW
9.3.3. PRODUCT OFFERED
9.3.4. KEY DEVELOPMENTS
9.3.5. KEY STRATEGIES
9.4. SANOFI
9.4.1. COMPANY OVERVIEW
9.4.2. PRODUCTS OFFERED
9.4.3. KEY DEVELOPMENTS
9.4.4. KEY STRATEGIES
9.5. TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.5.1. FINANCIAL OVERVIEW
9.5.2. PRODUCTS OFFERED
9.5.3. KEY DEVELOPMENTS
9.5.4. KEY STRATEGIES
9.6. FERRING B.V.
9.6.1. FINANCIAL OVERVIEW
9.6.2. PRODUCTS OFFERED
9.6.3. KEY DEVELOPMENTS
9.6.4. SWOT ANALYSIS
9.6.5. KEY STRATEGIES
9.7. DR. REDDY’S LABORATORIES LTD.
9.7.1. COMPANY OVERVIEW
9.7.2. PRODUCT OFFERED
9.7.3. KEY DEVELOPMENTS
9.8. FIDIA FARMACEUTICI S.P.A
9.8.1. COMPANY OVERVIEW
9.8.2. FINANCIAL OVERVIEW
9.8.3. PRODUCTS OFFERED
9.8.4. KEY DEVELOPMENTS
9.8.5. KEY STRATEGIES
9.9. SEMICAL BIOSURGERY
9.9.1. COMPANY OVERVIEW
9.9.2. FINANCIAL OVERVIEW
9.9.3. PRODUCTS OFFERED
9.9.4. KEY DEVELOPMENTS
9.9.5. KEY STRATEGIES
9.10. AVANOS MEDICAL, INC.
9.10.1. COMPANY OVERVIEW
9.10.2. FINANCIAL OVERVIEW
9.10.3. PRODUCTS OFFERED
9.10.4. KEY DEVELOPMENTS
9.10.5. KEY STRATEGIES
9.11. MAXIGEN BIOTECH INC. (MBI)
9.11.1. COMPANY
9.11.2. FINANCIAL OVERVIEW
9.11.3. PRODUCTS OFFERED
9.11.4. SWOT ANALYSIS
9.11.5. KEY STRATEGIES

10. QFD MODELING FOR MARKET SHARE ASSESSMENT

11. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, FOR HYALURONIC

12. GLOBAL COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY DISTRIBUTION

13. CANADA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION,

14. GERMANY: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION,

15. RUSSIA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION,

16. CHINA: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY PRODUCT

17. JAPAN: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION,

18. THAILAND: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY

19. BRAZIL: COLLAGEN AND HYALURONIC ACID INTRA-ARTICULAR INJECTIONS MARKET, BY APPLICATION,

20. BIOVENTUS, INC.: PRODUCTS OFFERED

21. AVANOS MEDICAL, INC.: PRODUCT OFFERED

22. (%)